Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Shanghai Junshi Biosciences Co., Ltd. has announced the election of Mr. Li Zhongxian and Ms. Lu Kun as independent non-executive directors, effective December 20, 2024. Both appointments were approved during the Extraordinary General Meeting, with each director set to receive an annual fee of RMB200,000. These changes are part of a strategic shift in the company’s audit and strategic committees.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue